Boston Scientific Rises
Boston Scientific (BSX ) says it sold $42 million worth of its Taxus drug-coated stents during an initial 10 selling days of Taxus between March 8 and March 19. CIBC World reiterated the sector outperform rating.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.